Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
85.62
-2.84 (-3.21%)
At close: Aug 20, 2026, 4:00 PM EDT
86.05
+0.43 (0.50%)
Pre-market: Aug 21, 2026, 8:45 AM EDT
Hinge Health Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Hinge Health stock has a consensus rating of "Buy" and an average price target of $106.47. The average 1-year stock price forecast is 24.35% higher than the current stock price, while the lowest is $85 (-0.72%) and the highest is $140 (+63.51%).
Price Target: $106.47 (+24.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hinge Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 8 | 8 | 8 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Reiterates $85 → $112 | Buy | Reiterates | $85 → $112 | +30.81% | Aug 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $110 | Buy | Maintains | $75 → $110 | +28.47% | Aug 5, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $90 → $96 | Buy | Maintains | $90 → $96 | +12.12% | Aug 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $100 → $105 | Buy | Reiterates | $100 → $105 | +22.63% | Aug 5, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $96 → $107 | Buy | Maintains | $96 → $107 | +24.97% | Aug 5, 2026 |
Financial Forecast
Revenue This Year
859.32M
from 587.86M
Increased by 46.18%
Revenue Next Year
1.09B
from 859.32M
Increased by 26.51%
EPS This Year
2.43
from 2.62
Decreased by -7.20%
EPS Next Year
3.13
from 2.43
Increased by 28.72%
EPS and Forward PE are based on non-GAAP adjusted numbers.